We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Abaloparatide vs DHEA: DHEA has the stronger overall evidence (5.5 vs 6/10); they're alternatives for bone health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
DHEA wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Probably helps
4 of 8 studies with measurable effects showed benefit.
Top outcomes
Approved regimen (Tymlos): 80 µg once daily by subcutaneous injection (abdomen), via a metered prefilled pen. This is a prescription drug — dose, duration and monitoring are set by a prescriber. The original 2-year cumulative-lifetime-use limit was REMOVED from the US label in 2021; duration is now an individualized clinical decision. There is no validated use outside osteoporosis fracture prevention.
any
Tymlos prefilled injector pen (prescription, via a clinician)
25-50mg for women; 50-100mg for men (start low)
Morning (mimics natural rhythm)
Micronized DHEA capsules
18 months
18 months
6-18 months
After discontinuation
4-8 weeks
8-12 weeks
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
JAMA (2016) · Rct · n=2463
Pivotal phase-3, double-blind ACTIVE RCT (n=2463 postmenopausal women, mean age 69) randomized to abaloparatide 80 µg/day, placebo, or open-label teriparatide 20 µg/day subcutaneously for 18 months
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
J Clin Endocrinol Metab (2018) · Rct · n=1139
Extension of ACTIVE: women who completed abaloparatide (ABL) or placebo (PBO) received up to 24 months of alendronate (ALN); 558 ABL and 581 PBO completers enrolled
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.
J Bone Miner Res (2022) · Rct · n=228
ATOM phase-3 RCT (n=228 men aged 40-85 with osteoporosis) randomized 2:1 to abaloparatide 80 µg/day or placebo subcutaneously for 12 months; primary endpoint was lumbar-spine BMD
Dehydroepiandrosterone for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials
Journal of neuroscience research (2020) · Meta analysis · n=742
No hormonal changes that indicated any risk to the participants' health were seen.
Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review
Annals of internal medicine (2024) · Systematic review
Vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may improve some GSM symptoms in the short term.
TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis
Reproductive biology and endocrinology : RB&E (2023) · Meta analysis · n=2323
Compared with the control group, CoQ10 (OR 2.22, 95% CI: 1.05 to 4.71) and DHEA (OR 1.92, 95% CI: 1.16 to 3.16) had obvious advantages in improving the clinical pregnancy rate.
Based on meta-analysis showing OR 1.92 for clinical pregnancy rate in poor ovarian response patients. Effect specific to fertility treatment context with medical supervision. Limited long-term safety data.
AI-estimated from published studies. Interpret as directional guidance.
DHEA has a higher evidence score (5.5/10 vs 6/10) and wins in 2 of 3 categories.
For bone health, Abaloparatide has a higher relevance score (80 vs 72).
No known interactions between Abaloparatide and DHEA have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.